Literature DB >> 21863361

The surgical treatment of lymphedema: a systematic review of the contemporary literature (2004-2010).

Janice N Cormier1, Loren Rourke, Melissa Crosby, David Chang, Jane Armer.   

Abstract

PURPOSE: A systematic review of the literature was performed to examine contemporary peer-reviewed literature (2004-2010) evaluating the surgical treatment of lymphedema.
METHODS: A comprehensive search of 11 major medical indices was performed. Selected articles were sorted to identify those related to the surgical treatment of lymphedema. Extracted data included the number of patients, specific surgical procedure performed, length of follow-up, criteria for defining lymphedema, measurement methods, volume or circumference reduction, and reported complications.
RESULTS: A total of 20 studies met inclusion criteria; procedures were categorized as excisional procedures (n = 8), lymphatic reconstruction (n = 8), and tissue transfer (n = 4). The reported incidence of volume reduction of lymphedema in these studies varied from 118% reduction to a 13% increase over the follow-up intervals ranging from 6 months to 15 years. The largest reported reductions were noted after excisional procedures (91.1%), lymphatic reconstruction (54.9%), and tissue transfer procedures (47.6%). Procedure complications were rarely reported.
CONCLUSIONS: A number of surgical approaches have demonstrated beneficial effects for select patients with lymphedema. Most of these reports, however, are based on small numbers of patients, use nonstandardized or inconsistent measurement techniques, and lack long-term follow-up. The proposed benefits of any surgical approach should be evaluated in the context of the potential morbidity to the individual patient and the availability of surgical expertise. In addition, although these surgical techniques have shown promising results, nearly all note that the procedures do not obviate the need for continued use of conventional therapies, including compression, for long-term maintenance.

Entities:  

Mesh:

Year:  2011        PMID: 21863361     DOI: 10.1245/s10434-011-2017-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  22 in total

Review 1.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 2.  [Complex decongestive therapy].

Authors:  B Heinig; U Wollina
Journal:  Hautarzt       Date:  2015-11       Impact factor: 0.751

Review 3.  Mechanical forces in lymphatic vascular development and disease.

Authors:  Lara Planas-Paz; Eckhard Lammert
Journal:  Cell Mol Life Sci       Date:  2013-05-12       Impact factor: 9.261

Review 4.  Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.

Authors:  Mei R Fu
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 5.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

Review 6.  Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review.

Authors:  Nikita Gupta; Erik M Verhey; Ricardo A Torres-Guzman; Francisco R Avila; Antonio Jorge Forte; Alanna M Rebecca; Chad M Teven
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-08-25

7.  Best Practice Guidelines in Assessment, Risk Reduction, Management, and Surveillance for Post-Breast Cancer Lymphedema.

Authors:  Jane M Armer; Jennifer M Hulett; Michael Bernas; Pam Ostby; Bob R Stewart; Janice N Cormier
Journal:  Curr Breast Cancer Rep       Date:  2013-06

8.  Analysis of factors contributing to severity of breast cancer-related lymphedema.

Authors:  Michelle Coriddi; Ibrahim Khansa; Julie Stephens; Michael Miller; James Boehmler; Pankaj Tiwari
Journal:  Ann Plast Surg       Date:  2015-01       Impact factor: 1.539

Review 9.  Lymphedema: Conventional to Cutting Edge Treatment.

Authors:  Duane Wang; Daniel Lyons; Roman Skoracki
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

10.  Lymphedema.

Authors:  Howard D Wang; Sachin M Shridharani; Anthony P Tufaro
Journal:  Eplasty       Date:  2013-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.